Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Supplemental Material - Non-Human Primate Husbandry and Impact on Non-Human Primates Health: Outcomes From an IQ DruSafe/3RS Industrial Benchmark Survey

Autor: Salian-Mehta, Smita, Poling, Jerry, Birkebak, Joanne, Rensing, Susanne, Carosino, Christopher, Santos, Rosemary, West, Wanda, Adams, Khary, Orsted, Kathy, Fillman-Holliday, Denise, Burns, Monika

Supplemental Material for Non-Human Primate Husbandry and Impact on Non-Human Primates Health: Outcomes From an IQ DruSafe/3RS Industrial Benchmark Survey by Smita Salian-Mehta1, Jerry Poling, Joanne Birkebak, Susanne Rensing, Chris Carosino, Rosemar

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d1f1318afdfdfbad4cff7040fb5e5c64

Towards in vitro models for reducing or replacing the use of animals in drug testing.

Autor: Stresser DM; Quantitative, Translational & ADME Sciences, AbbVie, North Chicago, IL, USA. david.stresser@abbvie.com.; International Consortium for Innovation and Quality in Pharmaceutical Development (IQ), . david.stresser@abbvie.com.; IQ Microphysiological Systems Affiliate (IQ-), . david.stresser@abbvie.com., Kopec AK; International Consortium for Innovation and Quality in Pharmaceutical Development (IQ).; IQ Microphysiological Systems Affiliate (IQ-).; Drug Safety Research & Development, Pfizer, Inc., Groton, CT, USA., Hewitt P; International Consortium for Innovation and Quality in Pharmaceutical Development (IQ).; IQ Microphysiological Systems Affiliate (IQ-).; Chemical and Preclinical Safety, Merck KGaA, Darmstadt, Germany., Hardwick RN; International Consortium for Innovation and Quality in Pharmaceutical Development (IQ).; IQ Microphysiological Systems Affiliate (IQ-).; Discovery Toxicology, Pharmaceutical Candidate Optimization, Bristol Myers Squibb, San Diego, CA, USA., Van Vleet TR; International Consortium for Innovation and Quality in Pharmaceutical Development (IQ).; IQ Microphysiological Systems Affiliate (IQ-).; Investigative Toxicology and Pathology, AbbVie, North Chicago, IL, USA., Mahalingaiah PKS; International Consortium for Innovation and Quality in Pharmaceutical Development (IQ).; IQ Microphysiological Systems Affiliate (IQ-).; Investigative Toxicology and Pathology, AbbVie, North Chicago, IL, USA., O'Connell D; International Consortium for Innovation and Quality in Pharmaceutical Development (IQ).; Global Animal Welfare, AbbVie, North Chicago, IL, USA.; IQ 3Rs (Replacement, Reduction, Refinement) Translational and Predictive Sciences Leadership Group., Jenkins GJ; Quantitative, Translational & ADME Sciences, AbbVie, North Chicago, IL, USA.; International Consortium for Innovation and Quality in Pharmaceutical Development (IQ).; IQ Translational and ADME Sciences Leadership Group (TALG)., David R; International Consortium for Innovation and Quality in Pharmaceutical Development (IQ).; IQ Microphysiological Systems Affiliate (IQ-).; Clinical Pharmacology & Safety Sciences, AstraZeneca, Cambridge, UK., Graham J; International Consortium for Innovation and Quality in Pharmaceutical Development (IQ).; Product Quality & Occupational Toxicology, Genentech, Inc., South San Francisco, CA, USA.; IQ DruSafe.; Safety Assessment, Genentech, Inc., South San Francisco, CA, USA., Lee D; International Consortium for Innovation and Quality in Pharmaceutical Development (IQ).; IQ 3Rs (Replacement, Reduction, Refinement) Translational and Predictive Sciences Leadership Group.; Safety Assessment, Genentech, Inc., South San Francisco, CA, USA., Ekert J; International Consortium for Innovation and Quality in Pharmaceutical Development (IQ).; IQ Microphysiological Systems Affiliate (IQ-).; UCB Pharma, Cambridge, MA, USA., Fullerton A; International Consortium for Innovation and Quality in Pharmaceutical Development (IQ).; IQ Microphysiological Systems Affiliate (IQ-).; Investigative Toxicology, Genentech, Inc., South San Francisco, CA, USA., Villenave R; International Consortium for Innovation and Quality in Pharmaceutical Development (IQ).; IQ Microphysiological Systems Affiliate (IQ-).; Roche Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd, Basel, Switzerland., Bajaj P; International Consortium for Innovation and Quality in Pharmaceutical Development (IQ).; IQ Microphysiological Systems Affiliate (IQ-).; Global Investigative Toxicology, Preclinical Safety, Sanofi, Cambridge, MA, USA., Gosset JR; International Consortium for Innovation and Quality in Pharmaceutical Development (IQ).; IQ Microphysiological Systems Affiliate (IQ-).; Pharmacokinetics, Dynamics and Metabolism, Medicine Design, Pfizer, Inc, Cambridge, MA, USA., Ralston SL; International Consortium for Innovation and Quality in Pharmaceutical Development (IQ).; IQ 3Rs (Replacement, Reduction, Refinement) Translational and Predictive Sciences Leadership Group.; Preclinical Safety, AbbVie, North Chicago, IL, USA., Guha M; International Consortium for Innovation and Quality in Pharmaceutical Development (IQ).; IQ Microphysiological Systems Affiliate (IQ-).; Discovery Biology, Incyte, Wilmington, DE, USA., Amador-Arjona A; International Consortium for Innovation and Quality in Pharmaceutical Development (IQ).; IQ Microphysiological Systems Affiliate (IQ-).; Discovery Biology, Incyte, Wilmington, DE, USA., Khan K; International Consortium for Innovation and Quality in Pharmaceutical Development (IQ).; IQ Microphysiological Systems Affiliate (IQ-).; Clinical Pharmacology & Safety Sciences, AstraZeneca, Cambridge, UK., Agarwal S; International Consortium for Innovation and Quality in Pharmaceutical Development (IQ).; IQ Microphysiological Systems Affiliate (IQ-).; Investigative Toxicology, Early Development, Alnylam Pharmaceuticals, Cambridge, MA, USA., Hasselgren C; International Consortium for Innovation and Quality in Pharmaceutical Development (IQ).; IQ DruSafe.; Predictive Toxicology, Genentech, Inc., South San Francisco, CA, USA., Wang X; International Consortium for Innovation and Quality in Pharmaceutical Development (IQ).; IQ Microphysiological Systems Affiliate (IQ-).; Translational Safety & Bioanalytical Sciences, Amgen Research, Amgen Inc., South San Francisco, CA, USA., Adams K; International Consortium for Innovation and Quality in Pharmaceutical Development (IQ).; IQ 3Rs (Replacement, Reduction, Refinement) Translational and Predictive Sciences Leadership Group.; Laboratory Animal Resources, Incyte, Wilmington, DE, USA., Kaushik G; International Consortium for Innovation and Quality in Pharmaceutical Development (IQ).; IQ Microphysiological Systems Affiliate (IQ-).; Nonclinical Drug Safety, Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, CT, USA., Raczynski A; International Consortium for Innovation and Quality in Pharmaceutical Development (IQ).; IQ Microphysiological Systems Affiliate (IQ-).; Preclinical Safety Assessment, Vertex Pharmaceuticals, Inc, Boston, MA, USA., Homan KA; International Consortium for Innovation and Quality in Pharmaceutical Development (IQ), . homan.kimberly@gene.com.; IQ Microphysiological Systems Affiliate (IQ-), . homan.kimberly@gene.com.; Complex in vitro Systems Group, Genentech, Inc., South San Francisco, CA, USA. homan.kimberly@gene.com.

Publikováno v: Nature biomedical engineering [Nat Biomed Eng] 2024 Aug; Vol. 8 (8), pp. 930-935.